<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<html>
<head>
<title></title>
</head>
<body link="#0000ff" vlink="#7f007f">
<p align="CENTER"><b><font size="5">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
</font>Washington, D.C. 20549</b></p>

<p align="CENTER"><b><font size="5">FORM 8-K</font></b></p>

<p align="CENTER"><b><font size="5">CURRENT REPORT</font><br>
</b>__________________________________________</p>

<p align="CENTER">Pursuant to Section 13 or 15 (d) of<br>
The Securities Exchange Act of 1934</p>

<p align="CENTER"><b>May 18, 2006</b><br>
Date of report (date of earliest event reported)</p>

<p align="CENTER"><b><u><font size="5">
&nbsp;&nbsp;&nbsp;&nbsp;FOREST LABORATORIES,
INC.&nbsp;&nbsp;&nbsp;&nbsp;<br>
</font></u></b> (Exact name of registrant as specified in its
charter)</p>

<center>
<table cellspacing="0" border="0" width="562">
<tr>
<td width="44%" valign="TOP">
<p align="CENTER"><b>Delaware<br>
</b><i>(State or other jurisdiction of<br>
incorporation or organization)</i></p>
</td>
<td width="18%" valign="TOP">
<p align="CENTER"><b>1-5438<br>
</b>(Commission<br>
 File Number)</p>
</td>
<td width="38%" valign="TOP">
<p align="CENTER"><b>11-1798614<br>
</b><i>(I.R.S. Employer<br>
Identification Number)</i></p>
</td>
</tr>

<tr>
<td width="44%" valign="TOP">&nbsp;</td>
<td width="18%" valign="TOP">&nbsp;</td>
<td width="38%" valign="TOP">&nbsp;</td>
</tr>

<tr>
<td width="44%" valign="TOP">
<p align="CENTER"><b>909 Third Avenue<br>
New York, New York<br>
</b> <i>(Address of principal executive offices)</i></p>
</td>
<td width="18%" valign="TOP">
<p>&nbsp;</p>
</td>
<td width="38%" valign="TOP">
<p align="CENTER"><b>10022-4731<br>
</b><i>(Zip code)</i></p>
</td>
</tr>
</table>
</center>

<p align="CENTER"><b>(212) 421-7850<br>
</b><i>(Registrant's telephone number, including area code)</i> <u>
<br>
<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>

</u> <i>(Former name or former address, if changed since last
report)<br>
</i></p>

<p><i>Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General
Instruction A.2. below):</i></p>

<p><font size="3">[&nbsp;]&nbsp;&nbsp;Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
[&nbsp;]&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)<br>
[&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))<br>
[&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<i><br>
</i></font></p>

<p align="JUSTIFY">&nbsp;</p>

<p>Item 5.02. <u>Departure of Directors or Principal Officers;
Election of Directors; Appointment of<br>
</u>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>
Principal Officers</u></p>

<p>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May 18, 2006, Forest&rsquo;s Board of Directors voted to increase
the size of the Board from six members to seven members and <a
name="HH_4">appointed</a> Nesli Basgoz, M.D. to fill the newly
created vacancy.</p>

<p>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.
Basgoz is currently a Physician in Medicine at Massachusetts
General Hospital and Associate Chief for Clinical Affairs in its
Division of Infectious Disease. She is also Director, Infectious
Disease Outpatient Services and Director, HIV Clinical Services.
Dr. Basgoz is also an Associate Professor of Medicine at Harvard
Medical School.</p>

<p>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
press release relating to Dr. Basgoz&rsquo;s appointment as
director is attached as <a href="exhibit99.htm"><font face="Times"
color="#800080">Exhibit 99</font></a> hereto and is incorporated by
reference herein.</p>

<p>Item 9.01. <u>Financial Statements and Exhibits</u></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;(c) <a href="exhibit99.htm"><font face=
"Times" color="#7F007F">Exhibit 99</font></a>. Press release of
Forest Laboratories, Inc. dated May 18, 2006.</p>

<p>&nbsp;</p>

<p align="CENTER"><font face="Courier"><a name="Quick_Links">
</a></font></p>

<p align="CENTER"><a name="STATEMENTS_OF_INCOME"></a>
SIGNATURES</p>

<p align="JUSTIFY">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly
authorized.</p>

<p align="JUSTIFY">Date: May 19, 2006</p>

<p align="JUSTIFY"><br>
<br>
</p>

<blockquote>
<div style="margin-left: 10em">
<p><u>Forest Laboratories, Inc.</u><br>
(Registrant)</p>

<p align="JUSTIFY"><br>
</p>

<p><u>/s/ Howard
Solomon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>
</u> Howard Solomon,<br>
Chairman of the Board</p>
</div>
</blockquote>

<p><a name="STATEMENTS_OF_COMPREHENSIVE_INCOME"></a></p>

<p><i>&nbsp;</i></p>

 <font face="Courier"></font>
<p align="RIGHT"><font face="Courier">&nbsp;</font></p>
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "forest8kmay06.htm", "description": "FOREST LABORATORIES, INC. 8-K MAY 19, 2006", "secsgml_size_bytes": 5792}]
{"company-data": {"conformed-name": "FOREST LABORATORIES INC", "cik": "0000038074", "assigned-sic": "2834", "irs-number": "111798614", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-05438", "film-number": "06856244"}, "business-address": {"street1": "909 THIRD AVENUE", "city": "NEW YORK", "state": "NY", "zip": "10022", "phone": "(212)421-7850"}, "mail-address": {"street1": "909 THIRD AVENUE", "city": "NEW YORK", "state": "NY", "zip": "10022"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
__________________________________________
Pursuant to Section 13 or 15 (d) of
The Securities Exchange Act of 1934
May 18, 2006
Date of report (date of earliest event reported)
FOREST LABORATORIES,
INC.
(Exact name of registrant as specified in its
charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
1-5438
(Commission
File Number)
11-1798614
(I.R.S. Employer
Identification Number)
909 Third Avenue
New York, New York
(Address of principal executive offices)
10022-4731
(Zip code)
(212) 421-7850
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General
Instruction A.2. below):
[ ]  Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]  Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
[ ]  Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
[ ]  Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02.
Departure of Directors or Principal Officers;
Election of Directors; Appointment of
Principal Officers
On
May 18, 2006, Forest's Board of Directors voted to increase
the size of the Board from six members to seven members and
appointed
Nesli Basgoz, M.D. to fill the newly
created vacancy.
Dr.
Basgoz is currently a Physician in Medicine at Massachusetts
General Hospital and Associate Chief for Clinical Affairs in its
Division of Infectious Disease. She is also Director, Infectious
Disease Outpatient Services and Director, HIV Clinical Services.
Dr. Basgoz is also an Associate Professor of Medicine at Harvard
Medical School.
A
press release relating to Dr. Basgoz's appointment as
director is attached as
Exhibit 99
hereto and is incorporated by
reference herein.
Item 9.01.
Financial Statements and Exhibits
(c)
Exhibit 99
. Press release of
Forest Laboratories, Inc. dated May 18, 2006.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly
authorized.
Date: May 19, 2006
Forest Laboratories, Inc.
(Registrant)
/s/ Howard
Solomon
Howard Solomon,
Chairman of the Board